Knowledge

Factor VIII (medication)

Source πŸ“

42: 1680: 451:
Factor VIII was first identified in the 1940s and became available as a medication in the 1960s. Recombinant factor VIII was first made in 1984 and approved for medical use in the United States in 1992. It is on the
509:
The cost of Factor VIII and similar clotting factors has been described as "highly expensive". The cost of the clotting factors is 80% of all medical costs for people with hemophilia. They are so expensive that
183: 1715: 1720: 346: 279: 138: 716: 946:
Biotechnology in blood transfusion: Proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen 1987, organized by the Red Cross Blood Bank Groningen-Drenthe
598: 75: 650: 676: 1254: 1567: 576: 1700: 453: 702: 1041: 967: 1000: 926: 994: 961: 920: 858: 1710: 825: 624: 1485: 1440: 367: 300: 168: 93: 1577: 1247: 1221: 1035: 885: 1209: 1197: 511: 406: 496:
synthesized factor products, which now prevent nearly all forms of disease transmission during replacement therapy.
112: 1670: 1372: 1705: 1533: 1240: 1055: 803: 1382: 1616: 1401: 123: 1185: 568: 492:
before purification methods were improved. In the early 1990s, pharmaceutical companies began to produce
1348: 523: 410: 1635: 465: 441: 85: 1562: 1352: 1111: 425: 1606: 1356: 1163: 1103: 1031: 1015: 990: 957: 941: 916: 854: 821: 529: 336: 269: 212: 195: 57: 982: 908: 1591: 1538: 1153: 1145: 1095: 1063: 1023: 949: 811: 744: 942:"In vivo characteristics of rDNA Factor VIII: The impact for the future in hemophilia care" 770: 1684: 1611: 1368: 1364: 1360: 1276: 1263: 547: 541: 535: 493: 1158: 1133: 1027: 257: 1222:"Antihemophilic Factor (recombinant), Glycopegylated-exei Monograph for Professionals" 1086:
Nathwani AC, Davidoff AM, Tuddenham EG (October 2017). "Gene Therapy for Hemophilia".
1694: 1511: 1506: 1464: 1306: 1149: 721: 1210:"Antihemophilic Factor (recombinant), Fc Fusion Protein Monograph for Professionals" 1640: 1496: 1479: 1430: 1386: 1267: 1198:"Antihemophilic Factor (Recombinant), Porcine Sequence Monograph for Professionals" 1115: 477: 437: 398: 151: 146: 877: 651:"Prescription medicines: registration of new chemical entities in Australia, 2014" 625:"Prescription medicines: registration of new chemical entities in Australia, 2016" 599:"Prescription medicines: registration of new chemical entities in Australia, 2017" 953: 1655: 1557: 1548: 1501: 1491: 1426: 1344: 1329: 1281: 481: 429: 402: 130: 1600: 1552: 1474: 1469: 1459: 1421: 1397: 1099: 445: 239: 436:
is safe for the fetus. A purified factor VIII concentrate is made from human
324: 1630: 1378: 1315: 1298: 489: 433: 421: 79: 33: 1167: 1107: 1060:
World Health Organization model list of essential medicines: 21st list 2019
1645: 1572: 1543: 1416: 1411: 1232: 394: 107: 1068: 17: 1020:
Blood Banking and Transfusion Medicine: Basic Principles & Practice
816: 514:
might be less expensive, especially for people with severe hemophilia.
41: 1624: 417: 1186:"Antihemophilic Factor (Recombinant) Monograph for Professionals" 677:"Prescription medicines and biologicals: TGA annual summary 2017" 448:
to factor VIII such that this medication becomes less effective.
376: 309: 218: 1236: 206: 102: 878:"Alphanate – Summary of Product Characteristics (SPC) – (eMC)" 485: 1134:"Gene therapy in hemophilia A: a cost-effectiveness analysis" 177: 416:
Side effects include skin flushing, shortness of breath,
1072:. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO. 717:"Health Canada New Drug Authorizations: 2016 Highlights" 190: 913:
Queen Victoria's Gene: Haemophilia and the Royal Family
454:
World Health Organization's List of Essential Medicines
948:. Springer Science & Business Media. p. 224. 405:. Certain preparations may also be used in those with 1668: 1590: 1526: 1450: 1328: 1297: 1290: 1275: 366: 361: 345: 335: 330: 299: 294: 278: 268: 263: 238: 233: 167: 162: 137: 122: 92: 74: 66: 56: 51: 853:. British Medical Association. 2015. p. 171. 484:often led to the transmission of diseases such as 1716:Drugs developed by Takeda Pharmaceutical Company 1081: 1079: 806:(2009). Stuart MC, Kouimtzi M, Hill SR (eds.). 1127: 1125: 1016:"Chapter 25 - Coagulation Factor Preparations" 810:. World Health Organization. pp. 259–60. 444:version is also available. People may develop 1721:World Health Organization essential medicines 1248: 8: 1088:Hematology/Oncology Clinics of North America 323: 256: 111: 32: 944:. In Sibinga CS, Das PC, Overby LR (eds.). 703:"Regulatory Decision Summary for Alphanate" 226:In general: β„ž (Prescription only) 1294: 1287: 1255: 1241: 1233: 1132:Machin N, Ragni MV, Smith KJ (July 2018). 798: 796: 794: 792: 550:, a recombinant antihemophilic factor VIII 544:, a recombinant antihemophilic factor VIII 538:, a recombinant antihemophilic factor VIII 532:, a recombinant antihemophilic factor VIII 526:, a recombinant antihemophilic factor VIII 393:is a medication used to treat and prevent 40: 1568:Tetragalacturonic acid hydroxymethylester 1157: 1067: 1022:. Elsevier Health Sciences. p. 353. 872: 870: 815: 851:British National Formulary : BNF 69 845: 843: 841: 839: 837: 1675: 560: 432:may occur. It is unclear if use during 681:Therapeutic Goods Administration (TGA) 655:Therapeutic Goods Administration (TGA) 629:Therapeutic Goods Administration (TGA) 603:Therapeutic Goods Administration (TGA) 322: 255: 31: 1062:. Geneva: World Health Organization. 480:byproduct into the blood stream of a 84: 7: 1044:from the original on 9 January 2017. 1003:from the original on 9 January 2017. 970:from the original on 9 January 2017. 929:from the original on 9 January 2017. 150: 981:Brownlee GG, Giangrande PL (2012). 888:from the original on 9 January 2017 579:from the original on 9 January 2017 1028:10.1016/B978-0-443-06981-9.50030-2 25: 1443:(II, VII, IX, X, protein C and S) 1678: 1150:10.1182/bloodadvances.2018021345 569:"Coagulation Factor VIII, Human" 1486:thrombopoietin receptor agonist 1441:Prothrombin complex concentrate 1701:Drugs not assigned an ATC code 1578:Hemostatic Powder Spray TC-325 983:"Clotting factors VIII and IX" 1: 1014:Zimring JC, Duncan A (2006). 954:10.1007/978-1-4613-1761-6_19 512:gene therapy for haemophilia 464:Factor VIII is delivered by 1737: 1373:Valoctocogene roxaparvovec 989:. BirkhΓ€user. p. 79. 411:slow injection into a vein 46:A depiction of factor VIII 1534:Absorbable gelatin sponge 1100:10.1016/j.hoc.2017.06.011 1056:World Health Organization 987:Recombinant Protein Drugs 804:World Health Organization 775:European Medicines Agency 749:European Medicines Agency 39: 1711:Drugs developed by Bayer 1383:Fidanacogene elaparvovec 808:WHO Model Formulary 2008 422:red blood cell breakdown 407:von Willebrand's disease 401:and other causes of low 62:Aafact, Kovaltry, others 1617:Aminomethylbenzoic acid 1018:. In Hillyer CD (ed.). 258:rurioctocog alfa pegol 1349:Damoctocog alfa pegol 985:. In Buckel P (ed.). 915:. The History Press. 524:Damoctocog alfa pegol 882:www.medicines.org.uk 466:intravenous infusion 500:Society and culture 476:This transfer of a 327: 260: 186:(Prescription only) 36: 27:Pharmaceutical drug 1563:Oxidized cellulose 1353:Efanesoctocog alfa 705:. 23 October 2014. 426:Allergic reactions 1666: 1665: 1636:Alfa1 antitrypsin 1607:Aminocaproic acid 1592:Antifibrinolytics 1586: 1585: 1522: 1521: 1357:Efmoroctocog alfa 1307:Phytomenadione (K 1144:(14): 1792–1798. 907:Potts DM (2011). 530:Efmoroctocog alfa 409:. It is given by 388: 387: 380: 321: 320: 313: 254: 253: 222: 210: 193: 181: 105: 16:(Redirected from 1728: 1706:Antihemorrhagics 1683: 1682: 1681: 1674: 1539:Calcium alginate 1295: 1288: 1277:Antihemorrhagics 1264:Antihemorrhagics 1257: 1250: 1243: 1234: 1229: 1217: 1205: 1193: 1172: 1171: 1161: 1129: 1120: 1119: 1083: 1074: 1073: 1071: 1052: 1046: 1045: 1011: 1005: 1004: 978: 972: 971: 940:High KA (2012). 937: 931: 930: 904: 898: 897: 895: 893: 874: 865: 864: 847: 832: 831: 819: 800: 787: 786: 784: 782: 767: 761: 760: 758: 756: 751:. 8 January 2018 741: 735: 734: 732: 730: 713: 707: 706: 699: 693: 692: 690: 688: 673: 667: 666: 664: 662: 647: 641: 640: 638: 636: 621: 615: 614: 612: 610: 595: 589: 588: 586: 584: 565: 378: 375: 328: 326: 311: 308: 261: 259: 220: 217: 208: 205: 201: 192: 189: 179: 176: 154: 115: 104: 101: 88: 44: 37: 35: 21: 1736: 1735: 1731: 1730: 1729: 1727: 1726: 1725: 1691: 1690: 1689: 1679: 1677: 1669: 1667: 1662: 1612:Tranexamic acid 1582: 1518: 1452: 1446: 1369:Turoctocog alfa 1365:Susoctocog alfa 1361:Moroctocog alfa 1331: 1324: 1319: 1310: 1279: 1271: 1261: 1220: 1208: 1196: 1184: 1181: 1176: 1175: 1131: 1130: 1123: 1085: 1084: 1077: 1054: 1053: 1049: 1038: 1013: 1012: 1008: 997: 980: 979: 975: 964: 939: 938: 934: 923: 906: 905: 901: 891: 889: 876: 875: 868: 861: 849: 848: 835: 828: 802: 801: 790: 780: 778: 769: 768: 764: 754: 752: 743: 742: 738: 728: 726: 725:. 14 March 2017 715: 714: 710: 701: 700: 696: 686: 684: 675: 674: 670: 660: 658: 649: 648: 644: 634: 632: 623: 622: 618: 608: 606: 597: 596: 592: 582: 580: 567: 566: 562: 557: 548:Turoctocog alfa 542:Susoctocog alfa 536:Moroctocog alfa 520: 507: 502: 474: 462: 460:Available forms 397:in people with 384: 357: 317: 290: 250: 229: 199: 158: 125: 118: 47: 28: 23: 22: 15: 12: 11: 5: 1734: 1732: 1724: 1723: 1718: 1713: 1708: 1703: 1693: 1692: 1688: 1687: 1664: 1663: 1661: 1660: 1659: 1658: 1650: 1649: 1648: 1643: 1638: 1633: 1621: 1620: 1619: 1614: 1609: 1596: 1594: 1588: 1587: 1584: 1583: 1581: 1580: 1575: 1570: 1565: 1560: 1555: 1546: 1541: 1536: 1530: 1528: 1524: 1523: 1520: 1519: 1517: 1516: 1515: 1514: 1509: 1504: 1499: 1494: 1482: 1477: 1472: 1467: 1462: 1456: 1454: 1448: 1447: 1445: 1444: 1434: 1433: 1424: 1419: 1414: 1405: 1404: 1391: 1390: 1376: 1342: 1336: 1334: 1326: 1325: 1323: 1322: 1317: 1313: 1308: 1303: 1301: 1292: 1285: 1273: 1272: 1262: 1260: 1259: 1252: 1245: 1237: 1231: 1230: 1218: 1206: 1194: 1180: 1179:External links 1177: 1174: 1173: 1138:Blood Advances 1121: 1094:(5): 853–868. 1075: 1047: 1036: 1006: 996:978-3034883467 995: 973: 963:978-1461317616 962: 932: 922:978-0752471969 921: 899: 866: 860:978-0857111562 859: 833: 826: 788: 777:. 2 March 2004 762: 745:"Adynovi EPAR" 736: 708: 694: 683:. 21 June 2022 668: 657:. 21 June 2022 642: 631:. 21 June 2022 616: 605:. 21 June 2022 590: 559: 558: 556: 553: 552: 551: 545: 539: 533: 527: 519: 516: 506: 503: 501: 498: 473: 470: 461: 458: 386: 385: 383: 382: 372: 370: 364: 363: 359: 358: 356: 355: 351: 349: 343: 342: 339: 333: 332: 319: 318: 316: 315: 305: 303: 297: 296: 292: 291: 289: 288: 284: 282: 276: 275: 272: 266: 265: 252: 251: 249: 248: 244: 242: 236: 235: 231: 230: 228: 227: 224: 215: 203: 187: 173: 171: 165: 164: 160: 159: 157: 156: 143: 141: 135: 134: 128: 126:administration 120: 119: 117: 116: 98: 96: 90: 89: 82: 72: 71: 68: 64: 63: 60: 54: 53: 49: 48: 45: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 1733: 1722: 1719: 1717: 1714: 1712: 1709: 1707: 1704: 1702: 1699: 1698: 1696: 1686: 1676: 1672: 1657: 1654: 1653: 1651: 1647: 1644: 1642: 1639: 1637: 1634: 1632: 1629: 1628: 1627: 1626: 1622: 1618: 1615: 1613: 1610: 1608: 1605: 1604: 1603: 1602: 1598: 1597: 1595: 1593: 1589: 1579: 1576: 1574: 1571: 1569: 1566: 1564: 1561: 1559: 1556: 1554: 1550: 1547: 1545: 1542: 1540: 1537: 1535: 1532: 1531: 1529: 1525: 1513: 1512:Rafutrombopag 1510: 1508: 1507:Lusutrombopag 1505: 1503: 1500: 1498: 1495: 1493: 1490: 1489: 1488: 1487: 1483: 1481: 1478: 1476: 1473: 1471: 1468: 1466: 1465:Carbazochrome 1463: 1461: 1458: 1457: 1455: 1449: 1442: 1439: 1438:combinations: 1436: 1435: 1432: 1428: 1425: 1423: 1420: 1418: 1415: 1413: 1410: 1407: 1406: 1403: 1399: 1396: 1393: 1392: 1388: 1384: 1380: 1377: 1374: 1370: 1366: 1362: 1358: 1354: 1350: 1346: 1343: 1341: 1338: 1337: 1335: 1333: 1327: 1321: 1314: 1312: 1305: 1304: 1302: 1300: 1296: 1293: 1289: 1286: 1283: 1278: 1274: 1269: 1265: 1258: 1253: 1251: 1246: 1244: 1239: 1238: 1235: 1227: 1223: 1219: 1215: 1211: 1207: 1203: 1199: 1195: 1191: 1187: 1183: 1182: 1178: 1169: 1165: 1160: 1155: 1151: 1147: 1143: 1139: 1135: 1128: 1126: 1122: 1117: 1113: 1109: 1105: 1101: 1097: 1093: 1089: 1082: 1080: 1076: 1070: 1065: 1061: 1057: 1051: 1048: 1043: 1039: 1033: 1029: 1025: 1021: 1017: 1010: 1007: 1002: 998: 992: 988: 984: 977: 974: 969: 965: 959: 955: 951: 947: 943: 936: 933: 928: 924: 918: 914: 910: 903: 900: 887: 883: 879: 873: 871: 867: 862: 856: 852: 846: 844: 842: 840: 838: 834: 829: 827:9789241547659 823: 818: 813: 809: 805: 799: 797: 795: 793: 789: 776: 772: 771:"Advate EPAR" 766: 763: 750: 746: 740: 737: 724: 723: 722:Health Canada 718: 712: 709: 704: 698: 695: 682: 678: 672: 669: 656: 652: 646: 643: 630: 626: 620: 617: 604: 600: 594: 591: 578: 574: 573:www.drugs.com 570: 564: 561: 554: 549: 546: 543: 540: 537: 534: 531: 528: 525: 522: 521: 517: 515: 513: 504: 499: 497: 495: 491: 487: 483: 479: 471: 469: 467: 459: 457: 455: 449: 447: 443: 439: 435: 431: 427: 423: 419: 414: 412: 408: 404: 400: 396: 392: 381: Rx-only 374: 373: 371: 369: 365: 360: 353: 352: 350: 348: 344: 340: 338: 334: 331:Clinical data 329: 314: Rx-only 307: 306: 304: 302: 298: 293: 286: 285: 283: 281: 277: 273: 271: 267: 264:Clinical data 262: 246: 245: 243: 241: 237: 232: 225: 223: Rx-only 216: 214: 204: 197: 188: 185: 175: 174: 172: 170: 166: 161: 153: 148: 145: 144: 142: 140: 136: 132: 129: 127: 121: 114: 109: 100: 99: 97: 95: 91: 87: 83: 81: 77: 73: 69: 65: 61: 59: 55: 52:Clinical data 50: 43: 38: 30: 19: 1641:C1-inhibitor 1623: 1599: 1497:Avatrombopag 1484: 1480:Fostamatinib 1437: 1431:Catridecacog 1422:I/Fibrinogen 1408: 1402:Eptacog alfa 1394: 1387:Nonacog alfa 1339: 1316:Menadione (K 1225: 1213: 1201: 1189: 1141: 1137: 1091: 1087: 1069:10665/325771 1059: 1050: 1019: 1009: 986: 976: 945: 935: 912: 902: 890:. Retrieved 881: 850: 807: 779:. Retrieved 774: 765: 753:. Retrieved 748: 739: 727:. Retrieved 720: 711: 697: 685:. Retrieved 680: 671: 659:. Retrieved 654: 645: 633:. Retrieved 628: 619: 607:. Retrieved 602: 593: 581:. Retrieved 572: 563: 508: 475: 463: 450: 438:blood plasma 415: 399:hemophilia A 390: 389: 368:Legal status 362:Legal status 325:octocog alfa 301:Legal status 295:Legal status 169:Legal status 163:Legal status 94:License data 70:octocog alfa 29: 1656:Ulinastatin 1601:amino acids 1558:Fibrin glue 1549:Epinephrine 1502:Eltrombopag 1492:Romiplostim 1417:II/Thrombin 1330:Coagulation 1282:coagulation 909:"Chapter 5" 817:10665/44053 494:recombinant 482:hemophiliac 442:recombinant 430:anaphylaxis 403:factor VIII 391:Factor VIII 337:Trade names 270:Trade names 234:Identifiers 131:Intravenous 67:Other names 58:Trade names 34:Factor VIII 1695:Categories 1553:adrenalone 1475:Etamsylate 1470:Concizumab 1460:Batroxobin 1395:extrinsic: 1340:intrinsic: 1037:0443069816 555:References 446:antibodies 428:including 240:ChemSpider 202:Schedule D 1652:unsorted 1631:Aprotinin 1299:Vitamin K 1226:Drugs.com 1214:Drugs.com 1202:Drugs.com 1190:Drugs.com 892:8 January 583:8 January 505:Economics 490:hepatitis 434:pregnancy 124:Routes of 86:Monograph 80:Drugs.com 1685:Medicine 1646:Camostat 1573:Thrombin 1544:Collagen 1453:systemic 1291:Systemic 1168:30042145 1108:28895852 1058:(2019). 1042:Archived 1001:Archived 968:Archived 927:Archived 886:Archived 687:31 March 661:10 April 635:10 April 577:Archived 518:See also 395:bleeding 347:ATC code 280:ATC code 139:ATC code 113:Kovaltry 108:DailyMed 18:Kogenate 1625:serpins 1409:common: 1332:factors 1159:6058236 1116:3779939 781:20 June 755:20 June 729:7 April 609:9 April 472:History 274:Adynovi 198: / 194:: 155:) 149: ( 147:B02BD02 110::  1671:Portal 1166:  1156:  1114:  1106:  1034:  993:  960:  919:  857:  824:  478:plasma 420:, and 341:Advate 213:β„ž-only 211: 200:  196:β„ž-only 182: 106:  1527:Local 1451:Other 1112:S2CID 418:fever 1427:XIII 1345:VIII 1164:PMID 1104:PMID 1032:ISBN 991:ISBN 958:ISBN 917:ISBN 894:2017 855:ISBN 822:ISBN 783:2024 757:2024 731:2024 689:2024 663:2023 637:2023 611:2023 585:2017 488:and 440:. A 354:None 287:None 247:none 133:(IV) 76:AHFS 1398:VII 1268:B02 1154:PMC 1146:doi 1096:doi 1064:hdl 1024:doi 950:doi 812:hdl 486:HIV 152:WHO 1697:: 1385:, 1381:/( 1379:IX 1371:, 1367:, 1363:, 1359:, 1355:, 1351:, 1347:/( 1224:. 1212:. 1200:. 1188:. 1162:. 1152:. 1140:. 1136:. 1124:^ 1110:. 1102:. 1092:31 1090:. 1078:^ 1040:. 1030:. 999:. 966:. 956:. 925:. 911:. 884:. 880:. 869:^ 836:^ 820:. 791:^ 773:. 747:. 719:. 679:. 653:. 627:. 601:. 575:. 571:. 468:. 456:. 424:. 413:. 377:EU 310:EU 219:EU 207:US 191:CA 184:S4 178:AU 103:US 1673:: 1551:/ 1429:/ 1412:X 1400:/ 1389:) 1375:) 1320:) 1318:3 1311:) 1309:1 1284:) 1280:( 1270:) 1266:( 1256:e 1249:t 1242:v 1228:. 1216:. 1204:. 1192:. 1170:. 1148:: 1142:2 1118:. 1098:: 1066:: 1026:: 952:: 896:. 863:. 830:. 814:: 785:. 759:. 733:. 691:. 665:. 639:. 613:. 587:. 379:: 312:: 221:: 209:: 180:: 78:/ 20:)

Index

Kogenate

Trade names
AHFS
Drugs.com
Monograph
License data
DailyMed
Kovaltry
Routes of
administration

Intravenous
ATC code
B02BD02
WHO
Legal status
S4
β„ž-only
β„ž-only
ChemSpider
Trade names
ATC code
Legal status
Trade names
ATC code
Legal status
bleeding
hemophilia A
factor VIII
von Willebrand's disease
slow injection into a vein

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑